Trials / Unknown
UnknownNCT03346317
Comparing the Efficacy of Two Methods in the Prevention of Adhesion Reformation After Hysteroscopic Adhesiolysis
Randomized, Controlled Trial to Assess the Efficacy of Disposable Balloon Uterine Stent Combined With Estrogen or Dried Biological Amnion Graft for the Therapy of Uterine Adhesion
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Beijing Obstetrics and Gynecology Hospital · Academic / Other
- Sex
- Female
- Age
- 20 Years – 40 Years
- Healthy volunteers
- Not accepted
Summary
Asherman's syndrome is characterized by the presence of intrauterine adhesions (IUA) as well as symptoms such as amenorrhea, hypomenorrhea, pelvic pain, and infertility. The gold standard for the treatment of intrauterine adhesions is hysteroscopic intrauterine adhesions. The recurrence of intrauterine adhesions is a major challenge in clinical practice. It has been reported that dried biological aminion graft was used to prevent adhesion after the operation of intrauterine adhesions. Estrogen is also used for postoperative prevention of intrauterine adhesions. Intrauterine balloon can reduce the recurrence of adhesions after operation. Does the combination of balloon with amniotic products or estrogen can improve clinical outcomes? Therefore, this study was conducted.
Detailed description
Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Double (participant and outcomes Assessor) Primary Purpose: Prevention
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | disposable balloon uterine stent | The disposable balloon uterine stent is heart-shaped that resembled the shape of the uterine cavity and could fully separate the two sides of the uterine wall and the corners of the uterus compare to Foley catheter. |
| PROCEDURE | dried biological amnion graft | Uterine application of amnion membrane following hysteroscopic adhesiolysis. Other Name: Human amnion membrane |
| DRUG | estradiol valerate tablets+dydrogesterone tablets | oral estradiol valerate tablets+dydrogesterone tablets |
Timeline
- Start date
- 2017-11-16
- Primary completion
- 2018-05-16
- Completion
- 2018-05-20
- First posted
- 2017-11-17
- Last updated
- 2017-11-20
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03346317. Inclusion in this directory is not an endorsement.